XOMA Royalty (XOMA) Non Operating Investment Income (2024 - 2026)

XOMA Royalty (XOMA) reported Non Operating Investment Income of $933000.0 for Q1 2026, up 0.65% on a YoY basis from $927000.0 in Q1 2025, and up 12.0% sequentially from $833000.0 in Q4 2025.

XOMA Royalty (XOMA) Non Operating Investment Income (2024 - 2026) Analysis & Trends

XOMA Royalty (XOMA) has 3 years of Non Operating Investment Income data on file, last reported at $933000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Non Operating Investment Income rose 0.65% year-over-year to $933000.0; the trailing twelve-month figure through Mar 2026 stood at $3.5 million (down 38.1% YoY), and the FY2025 full-year result was $3.5 million, down 46.56% from the prior year.
  • Non Operating Investment Income advanced to $933000.0 in Q1 2026, from $833000.0 in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $1.7 million in Q3 2024 to a low of $833000.0 in Q4 2025.
  • A 3-year average of $1.2 million and a median of $933000.0 in 2026 frame the typical range for Non Operating Investment Income.
  • Across the five-year window, Non Operating Investment Income slumped 49.88% in 2025 and gained 0.65% in 2026, its largest moves.
  • Tracing XOMA's Non Operating Investment Income over 3 years: stood at $1.4 million in 2024, then tumbled by 40.71% to $833000.0 in 2025, then gained by 12.0% to $933000.0 in 2026.
  • Business Quant data shows XOMA's Non Operating Investment Income at $933000.0 in Q1 2026, $833000.0 in Q4 2025, and $843000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 XOMA Royalty 478.42 Mn 412.34 Mn - 933,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 933,000.00
Mar 31, 2026 933,000.00
Dec 31, 2025 833,000.00
Dec 31, 2025 833,000.00
Jun 30, 2025 843,000.00
Jun 30, 2025 843,000.00
Mar 31, 2025 927,000.00
Mar 31, 2025 927,000.00
Dec 31, 2024 1.41 Mn
Dec 31, 2024 1.41 Mn
Sep 30, 2024 1.70 Mn
Sep 30, 2024 1.70 Mn
Jun 30, 2024 1.68 Mn
Jun 30, 2024 1.68 Mn